Subscribe To
Here's why novartis (nvs) is a strong value stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Pre...
March 9, 2023, 11:25 am
5 large drug stocks to watch as sector picks up in 2023
Drug/biotech companies are likely to see significant advances in innovation in 2023. In the Large-Cap Pharmaceuticals industry, J&J (JNJ), Novo Nordis...
March 9, 2023, 9:11 am
novartis: cautiously optimistic, hold
Several of novartis' blockbuster drugs are nearing patent expiry, but the company's late-stage pipeline...
March 6, 2023, 7:31 pm
After plunging -7.17% in 4 weeks, here's why the trend might reverse for novartis (nvs)
The heavy selling pressure might have exhausted for novartis (NVS) as it is technically in oversold ter...
March 1, 2023, 11:18 am
novartis crosses below key moving average level
In trading on Tuesday, shares of novartis crossed below their 200 day moving average of $85.10, changin...
February 28, 2023, 11:06 am
Molecular partners presents new preclinical data supporting its radio darpin therapy platform
Proprietary Radio DARPin Therapy Platform designed to deliver high amount of radioactivity to the tumor while maintaining low accumulation in other ti...
February 28, 2023, 6:15 am
novartis names firmenich ceo as chairman designate of sandoz
novartis on Monday announced the appointment of Gilbert Ghostine as chairman-designate of Sandoz, the g...
February 20, 2023, 1:34 am
[latest] global gene therapy market size/share worth usd 7247.58 million by 2028 at a 20.10% cagr: facts & factors (industrial trends, report, analysis, players, outlook, forecast, growth, cagr, overv
The key market players listed in the gene therapy report with their sales, revenues and strategies are novarti...
February 17, 2023, 7:26 am
novartis (nvs) q4 earnings top, revenues miss estimates
novartis (NVS) reports mixed fourth-quarter results, with key brands maintaining momentum but Cosentyx ...
February 1, 2023, 3:03 pm
novartis ag (nvs) q4 2022 earnings call transcript
novartis AG (NYSE:NVS ) Q4 2022 Earnings Conference Call February 1, 2023 8:00 AM ET Company Participan...
February 1, 2023, 10:15 am
Pharma giants gsk, novo nordisk beat expectations; but novartis dives on a mixed report
GSK stock and NVO stock rose Wednesday on fourth-quarter beats, but novartis stock fell on lighter-than...
February 1, 2023, 9:16 am
Dow jones newswires: novartis posts lower sales and profit on generic competition, but boosts 2022 dividend
The Swiss pharma major posted net profit of $1.47 billion, down from $16.31 billion the year prior, when it benefited from the sale of its investment ...
February 1, 2023, 6:39 am
novartis posts lower sales and profit on generic competition, but boosts 2022 dividend
By Cecilia Butini...
February 1, 2023, 1:39 am
Could this be novartis' next blockbuster medicine?
The Swiss drugmaker recently shared promising phase 3 clinical trial results for this rare-disease drug....
January 27, 2023, 8:45 am
novartis ceo: nations pulling back on health care spending ‘has long-term consequences'
novartis CEO Vasant Narasimhan joins Yahoo Finance Live's Julie Hyman at the 2023 World Economic Forum ...
January 20, 2023, 2:40 pm
Why bristol myers squibb is the better buy from u.s. large cap pharma
While foreign competitors novartis and Roche scored better than Bristol Myers in my recent pipeline ana...
January 18, 2023, 2:04 am
novartis generated $40 billion in innovative medicine sales, says ceo
CNBC's Meg Tirrell sits down with Dr. Vas Narasimhan, CEO of novartis International on drug development...
January 10, 2023, 12:51 pm
novartis ag (nvs) 41st annual j.p. morgan healthcare conference (transcript)
novartis AG (NYSE:NVS ) 41st Annual J.P. Morgan Healthcare Conference Call January 9, 2023 11:15 AM ET ...
January 9, 2023, 3:16 pm
Royalty pharma agrees to buy ionis pharma royalties for $1.125 bln
Royalty Pharma Plc RPRX, -1.42% said Monday it agreed to pay up to $1.125 billion for drug royalties owned by Ionis Pharmaceuticals Inc. IONS, +1.00% ...
January 9, 2023, 9:24 am
novartis to pay $245 mln to end antitrust cases over exforge drug generics
novartis AG said on Wednesday it will pay $245 million to end antitrust litigation accusing the Swiss d...
December 28, 2022, 7:46 pm